TherapeuticsMD Inc. (NASDAQ: TXMD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT THERAPEUTICSMD INC.

TherapeuticsMD Inc. (NASDAQ: TXMD)
Listen to this Section


$2.04
-0.0050 ( -0.25% ) 25.5K

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Clinical Trial Pipeline Stages


Drug Name Stage
TX-004HR: IMVEXXY™ (estradiol vaginal inserts)DetailsDyspareunia (Moderate to Severe) Approved
ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System)DetailsBirth Control (Contraception) Approved
TX-001HR: BIJUVA™ (Estradiol and Progesterone)DetailsModerate to Severe Vasomotor Symptoms Due to Menopause Approved

Market Data


Open $2.04
Previous Close $2.04
Volume 25.5K
Market Cap $23.61M
Day Range $1.98 - $2.11
52 Week Range $0.98 - $2.95
Shares Outstanding 11.57M
Change % -0.25%
Net Change ▼ -0.0050
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2002
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -947,447.00

Date Type Amount Purchased Purchaser
2025-04-15 Buy 490.00 Walker Marlan D
2025-04-15 Buy 325.00 Thompson Tommy G
2025-04-10 Buy 1136.00 Walker Marlan D
2024-08-26 Buy 4094.00 Collins Cooper C.
2024-08-23 Buy 1200.00 Collins Cooper C.
2023-12-07 Sale -70000.00 Walker Marlan D
2023-11-17 Sale -877192.00 Rubric Capital Management LP
2023-08-21 Sale -7500.00 ZIEGLER JOSEPH

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 13, 2025
10-q Quarterly Reports 68 Nov 12, 2025
4 Insider transactions 1 Nov 05, 2025
4 Insider transactions 1 Nov 05, 2025
4 Insider transactions 1 Nov 05, 2025
4 Insider transactions 1 Nov 05, 2025
def Proxies and info statements 27 Nov 03, 2025
ars Annual reports 1 Nov 03, 2025
pre Proxies and info statements 27 Oct 24, 2025
8-k 8K-related 14 Aug 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy